WO2001081622A3 - Diagnosis of diseases associated with dna repair - Google Patents

Diagnosis of diseases associated with dna repair Download PDF

Info

Publication number
WO2001081622A3
WO2001081622A3 PCT/EP2001/003972 EP0103972W WO0181622A3 WO 2001081622 A3 WO2001081622 A3 WO 2001081622A3 EP 0103972 W EP0103972 W EP 0103972W WO 0181622 A3 WO0181622 A3 WO 0181622A3
Authority
WO
WIPO (PCT)
Prior art keywords
dna repair
diagnosis
diseases associated
genes associated
pna
Prior art date
Application number
PCT/EP2001/003972
Other languages
French (fr)
Other versions
WO2001081622A2 (en
WO2001081622A8 (en
Inventor
Alexander Olek
Christian Piepenbrock
Kurt Berlin
Original Assignee
Epigenomics Ag
Alexander Olek
Christian Piepenbrock
Kurt Berlin
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE10019058A external-priority patent/DE10019058A1/en
Priority claimed from DE10032529A external-priority patent/DE10032529A1/en
Application filed by Epigenomics Ag, Alexander Olek, Christian Piepenbrock, Kurt Berlin filed Critical Epigenomics Ag
Priority to US10/240,589 priority Critical patent/US20040076956A1/en
Priority to EP01956429A priority patent/EP1370685A2/en
Priority to AU2001278420A priority patent/AU2001278420A1/en
Publication of WO2001081622A2 publication Critical patent/WO2001081622A2/en
Publication of WO2001081622A8 publication Critical patent/WO2001081622A8/en
Publication of WO2001081622A3 publication Critical patent/WO2001081622A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • C07K14/4703—Inhibitors; Suppressors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers

Abstract

The present invention relates to the chemically modified genomic sequences of genes associated with DNA repair, to oligonucleotides and/or PNA-oligomers for detecting the cytosine methylation state of genes associated with DNA repair which are directed against the sequence, as well as to a method for ascertaining genetic and/or epigenetic parameters of genes associated with DNA repair.
PCT/EP2001/003972 2000-04-06 2001-04-06 Diagnosis of diseases associated with dna repair WO2001081622A2 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US10/240,589 US20040076956A1 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with dna repair
EP01956429A EP1370685A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with dna repair
AU2001278420A AU2001278420A1 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with dna repair

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
DE10019058.8 2000-04-06
DE10019058A DE10019058A1 (en) 2000-04-06 2000-04-06 Designing primers and probes for analyzing diseases associated with cytosine methylation state e.g. arthritis, cancer, aging, arteriosclerosis comprising fragments of chemically modified genes associated with cell cycle
DE10019173 2000-04-07
DE10019173.8 2000-04-07
DE10032529.7 2000-06-30
DE10032529A DE10032529A1 (en) 2000-06-30 2000-06-30 Diagnosis of major genetic parameters within the Major Histocompatibility Complex (MHC)
DE10043826 2000-09-01
DE10043826.1 2000-09-01

Publications (3)

Publication Number Publication Date
WO2001081622A2 WO2001081622A2 (en) 2001-11-01
WO2001081622A8 WO2001081622A8 (en) 2002-05-16
WO2001081622A3 true WO2001081622A3 (en) 2003-09-04

Family

ID=27437807

Family Applications (8)

Application Number Title Priority Date Filing Date
PCT/EP2001/003969 WO2001077164A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
PCT/EP2001/004015 WO2001077378A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with dna adducts
PCT/EP2001/004016 WO2001076451A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with metabolism
PCT/EP2001/003972 WO2001081622A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with dna repair
PCT/EP2001/003968 WO2001077375A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with gene regulation
PCT/EP2001/003973 WO2001092565A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription
PCT/EP2001/003970 WO2001077376A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with metastasis
PCT/EP2001/003971 WO2001077377A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with dna replication by assessing dna methylation

Family Applications Before (3)

Application Number Title Priority Date Filing Date
PCT/EP2001/003969 WO2001077164A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
PCT/EP2001/004015 WO2001077378A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with dna adducts
PCT/EP2001/004016 WO2001076451A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with metabolism

Family Applications After (4)

Application Number Title Priority Date Filing Date
PCT/EP2001/003968 WO2001077375A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with gene regulation
PCT/EP2001/003973 WO2001092565A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated dna transcription by means of assessing the methylation status of genes associated with dna transcription
PCT/EP2001/003970 WO2001077376A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with metastasis
PCT/EP2001/003971 WO2001077377A2 (en) 2000-04-06 2001-04-06 Diagnosis of diseases associated with dna replication by assessing dna methylation

Country Status (7)

Country Link
US (7) US20040067491A1 (en)
EP (9) EP1360319A2 (en)
JP (3) JP2003531589A (en)
AT (1) ATE353975T1 (en)
AU (9) AU2001275663A1 (en)
DE (1) DE60126593T2 (en)
WO (8) WO2001077164A2 (en)

Families Citing this family (79)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780982B2 (en) 1996-07-12 2004-08-24 Third Wave Technologies, Inc. Charge tags and the separation of nucleic acid molecules
US6818404B2 (en) 1997-10-23 2004-11-16 Exact Sciences Corporation Methods for detecting hypermethylated nucleic acid in heterogeneous biological samples
US7955794B2 (en) 2000-09-21 2011-06-07 Illumina, Inc. Multiplex nucleic acid reactions
US7582420B2 (en) 2001-07-12 2009-09-01 Illumina, Inc. Multiplex nucleic acid reactions
US8076063B2 (en) 2000-02-07 2011-12-13 Illumina, Inc. Multiplexed methylation detection methods
WO2001077164A2 (en) * 2000-04-06 2001-10-18 Epigenomics Ag Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
US20040052763A1 (en) * 2000-06-07 2004-03-18 Mond James J. Immunostimulatory RNA/DNA hybrid molecules
AU2001277521A1 (en) * 2000-06-30 2002-01-14 Epigenomics Ag Diagnosis of diseases associated with cell signalling
AUPR142500A0 (en) * 2000-11-13 2000-12-07 Human Genetic Signatures Pty Ltd A peptide nucleic acid-based assay for the detection of specific nucleic acid sequences
DE10128508A1 (en) 2001-06-14 2003-02-06 Epigenomics Ag Methods and nucleic acids for the differentiation of prostate tumors
AU2002342004A1 (en) 2001-10-05 2003-04-22 Case Western Reserve University Methods and compositions for detecting colon cancers
JP2003144172A (en) * 2001-11-16 2003-05-20 Nisshinbo Ind Inc Oligonucleotide-immobilized board for detecting methylation
US20110151438A9 (en) 2001-11-19 2011-06-23 Affymetrix, Inc. Methods of Analysis of Methylation
DE10161625A1 (en) * 2001-12-14 2003-07-10 Epigenomics Ag Methods and nucleic acids for the analysis of a pulmonary cell division disorder
WO2003076593A2 (en) 2002-03-07 2003-09-18 The Johns Hopkins University School Of Medicine Genomic screen for epigenetically silenced genes associated with cancer
EP1344832A1 (en) * 2002-03-15 2003-09-17 Epigenomics AG Methods and nucleic acids for the analysis of methylation within the gene melastatin
AU2003225983A1 (en) * 2002-03-25 2003-10-13 St. Jude Children's Research Hospital Cpg retrieval of dna from formalin-fixed pathology specimen for promoter methylation analysis
AU2003247880B2 (en) * 2002-07-03 2010-09-02 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US7807803B2 (en) 2002-07-03 2010-10-05 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
US20040053880A1 (en) 2002-07-03 2004-03-18 Coley Pharmaceutical Group, Inc. Nucleic acid compositions for stimulating immune responses
ES2447566T3 (en) * 2002-10-01 2014-03-12 Epigenomics Ag Use of PITX2 nucleic acids to improve the treatment of breast cell proliferative disorders
US20060094016A1 (en) * 2002-12-02 2006-05-04 Niall Gormley Determination of methylation of nucleic acid sequences
DE10304219B3 (en) * 2003-01-30 2004-08-19 Epigenomics Ag Method for the detection of cytosine methylation patterns with high sensitivity
WO2004070062A2 (en) * 2003-02-04 2004-08-19 Wyeth Compositions and methods for diagnosing and treating cancers
US20050009059A1 (en) * 2003-05-07 2005-01-13 Affymetrix, Inc. Analysis of methylation status using oligonucleotide arrays
WO2004111266A1 (en) 2003-06-17 2004-12-23 Human Genetic Signatures Pty Ltd Methods for genome amplification
JP4781267B2 (en) * 2003-08-14 2011-09-28 ケース ウエスタン リザーブ ユニバーシティ Method and composition for detecting colorectal cancer
US8415100B2 (en) 2003-08-14 2013-04-09 Case Western Reserve University Methods and compositions for detecting gastrointestinal and other cancers
DE10338308B4 (en) 2003-08-15 2006-10-19 Epigenomics Ag Method for the detection of cytosine methylations in DNA
ATE419394T1 (en) 2003-09-04 2009-01-15 Human Genetic Signatures Pty NUCLEIC ACID DETECTION TEST
WO2005038047A1 (en) * 2003-10-20 2005-04-28 St Vincent's Hospital (Sydney) Limited Assessment of disease risk by quantitative determination of epimutation in normal tissues
EP3269826B1 (en) * 2003-12-01 2020-03-11 Epigenomics AG Methods and nucleic acids for the analysis of gene expression associated with the development of prostate cell proliferative disorders
EP1561821B1 (en) 2003-12-11 2011-02-16 Epigenomics AG Prognostic markers for prediction of treatment response and/or survival of breast cell proliferative disorder patients
US20050196792A1 (en) * 2004-02-13 2005-09-08 Affymetrix, Inc. Analysis of methylation status using nucleic acid arrays
US8168777B2 (en) 2004-04-29 2012-05-01 Human Genetic Signatures Pty. Ltd. Bisulphite reagent treatment of nucleic acid
JP4980219B2 (en) 2004-09-10 2012-07-18 ヒューマン ジェネティック シグネチャーズ ピーティーワイ リミテッド Amplification blocker comprising intercalating nucleic acid (INA) containing intercalated pseudonucleotide (IPN)
KR20060026595A (en) 2004-09-21 2006-03-24 (주)지노믹트리 Method for detecting methylaion of promoter using restriction enzyme and dna chip
KR100617649B1 (en) * 2004-09-24 2006-09-04 (주)지노믹트리 Composition For Cancer diagnosis Containing Methylated Promoters of Colon Cancer Specific Expression-decreased Genes and Use Thereof
CN101111606B (en) 2004-12-03 2012-05-16 人类遗传标记控股有限公司 Methods for simplifying microbial nucleic acids by chemical modification of cytosines
US20060134650A1 (en) * 2004-12-21 2006-06-22 Illumina, Inc. Methylation-sensitive restriction enzyme endonuclease method of whole genome methylation analysis
EP1693468A1 (en) 2005-02-16 2006-08-23 Epigenomics AG Method for determining the methylation pattern of a polynucleic acid
WO2006113770A1 (en) 2005-04-15 2006-10-26 Epigenomics Ag A method for providing dna fragments derived from a remote sample
WO2006111586A2 (en) * 2005-04-20 2006-10-26 Proyecto De Biomedicina Cima, S.L. Method for the in vitro determination of the degree of methylation of the line-1 promoter
US8431347B2 (en) 2005-05-26 2013-04-30 Human Genetic Signatures Pty Ltd Isothermal strand displacement amplification using primers containing a non-regular base
US20060292585A1 (en) * 2005-06-24 2006-12-28 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US8343738B2 (en) 2005-09-14 2013-01-01 Human Genetic Signatures Pty. Ltd. Assay for screening for potential cervical cancer
DK1974058T3 (en) 2006-01-11 2014-09-01 Genomic Health Inc Gene Expression Markers for Prognostication of Colorectal Cancer
US7465544B2 (en) * 2006-01-11 2008-12-16 Wisconsin Alumni Research Foundation Synthetic cofactor analogs of S-adenosylmethionine as ligatable probes of biological methylation and methods for their use
EP1826279B1 (en) 2006-02-28 2011-05-04 Charité - Universitätsmedizin Berlin Detection and quality control of regulatory T cells through DNA-methylation analysis of the FoxP3 gene
US7901882B2 (en) 2006-03-31 2011-03-08 Affymetrix, Inc. Analysis of methylation using nucleic acid arrays
US20090104615A1 (en) * 2006-05-02 2009-04-23 Keith Malcolm Godfrey Phenotype prediction
US8084734B2 (en) * 2006-05-26 2011-12-27 The George Washington University Laser desorption ionization and peptide sequencing on laser induced silicon microcolumn arrays
WO2008096146A1 (en) 2007-02-07 2008-08-14 Solexa Limited Preparation of templates for methylation analysis
JP2011501674A (en) * 2007-10-23 2011-01-13 クリニカル・ジェノミックス・プロプライエタリー・リミテッド Diagnosis of type 2 neoplasia (NEOPLASMS-II)
CA2706740C (en) 2007-11-27 2017-01-17 Human Genetic Signatures Pty Ltd Enzymes for amplification and copying bisulphite modified nucleic acids
EP2660337B1 (en) 2008-07-15 2016-09-14 Epigenomics AG Method of prediciting the prognosis of a breast cancer therapy based on gene methylation analysis
US8541207B2 (en) 2008-10-22 2013-09-24 Illumina, Inc. Preservation of information related to genomic DNA methylation
US8110796B2 (en) 2009-01-17 2012-02-07 The George Washington University Nanophotonic production, modulation and switching of ions by silicon microcolumn arrays
US9490113B2 (en) * 2009-04-07 2016-11-08 The George Washington University Tailored nanopost arrays (NAPA) for laser desorption ionization in mass spectrometry
MX2011011571A (en) 2009-05-01 2012-02-13 Genomic Health Inc Gene expression profile algorithm and test for likelihood of recurrence of colorectal cancer and response to chemotherapy.
EP2470673B1 (en) 2009-08-28 2014-07-30 Cellular Dynamics International, Inc. Identifying genetic variation in affected tissues
US20130195884A1 (en) * 2009-12-31 2013-08-01 Deutsches Krebsforschungszentrum Novel modulators of trail signalling
BR112013027583A2 (en) * 2011-04-28 2016-09-06 Alexander Pearlman genomic signatures of metastases in prostate cancer
US10435743B2 (en) 2011-05-20 2019-10-08 The Regents Of The University Of California Method to estimate age of individual based on epigenetic markers in biological sample
ES2613743T3 (en) 2011-09-07 2017-05-25 Human Genetic Signatures Pty Ltd Molecular detection assay
WO2013129397A1 (en) * 2012-02-29 2013-09-06 シスメックス株式会社 Method for determining presence or absence of cancer cell derived from hepatocellular carcinoma, and determination marker and kit
US9732390B2 (en) 2012-09-20 2017-08-15 The Chinese University Of Hong Kong Non-invasive determination of methylome of fetus or tumor from plasma
US10706957B2 (en) 2012-09-20 2020-07-07 The Chinese University Of Hong Kong Non-invasive determination of methylome of tumor from plasma
KR101302173B1 (en) 2012-12-07 2013-08-30 이화여자대학교 산학협력단 Composition for diagnosing alzheimer's disease using methylation status of hmox1 gene and method for diagnosing alzheimer's disease using the same
US20140274757A1 (en) 2013-03-14 2014-09-18 Marie K. Kirby Differential Methylation Level of CpG Loci That Are Determinative of a Biochemical Reoccurrence of Prostate Cancer
US20170051354A1 (en) * 2014-04-28 2017-02-23 Sigma-Aldrich Co. Llc Epigenetic modification of mammalian genomes using targeted endonucleases
EP3850083A4 (en) * 2018-09-14 2022-06-29 Shinozaki, Gen Systems and methods for detection of delirium risk using epigenetic markers
CN111217900A (en) * 2018-11-27 2020-06-02 上海交通大学 Transcription regulation factor for angiogenesis and application thereof
JP7320067B2 (en) 2019-01-18 2023-08-02 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア DNA methylation measurements for mammals based on conserved loci
WO2021075797A2 (en) 2019-10-14 2021-04-22 주식회사 젠큐릭스 Composition for diagnosing liver cancer by using cpg methylation changes in specific genes, and use thereof
KR102637032B1 (en) 2020-01-28 2024-02-15 주식회사 젠큐릭스 Composition for diagnosing bladder cancer using CpG methylation status of specific gene and uses thereof
WO2021206467A1 (en) 2020-04-08 2021-10-14 주식회사 젠큐릭스 Composition for diagnosing colorectal cancer, rectal cancer, or colorectal adenoma using cpg methylation change of glrb gene, and use thereof
CN111500702B (en) * 2020-04-26 2021-04-20 江苏大学附属医院 Application of cg00843506 site methylation of RPN1 gene in diagnosing asthma
WO2023175019A1 (en) 2022-03-15 2023-09-21 Genknowme S.A. Method determining the difference between the biological age and the chronological age of a subject

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744305A (en) * 1989-06-07 1998-04-28 Affymetrix, Inc. Arrays of materials attached to a substrate
WO1998056952A1 (en) * 1997-06-09 1998-12-17 University Of Southern California A cancer diagnostic method based upon dna methylation differences
WO1999028498A2 (en) * 1997-11-27 1999-06-10 Epigenomics Gmbh Method for producing complex dna methylation fingerprints
WO2001068911A2 (en) * 2000-03-15 2001-09-20 Epigenomics Ag Diagnosis of diseases associated with the cell cycle

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5474796A (en) * 1991-09-04 1995-12-12 Protogene Laboratories, Inc. Method and apparatus for conducting an array of chemical reactions on a support surface
SE501439C2 (en) 1993-06-22 1995-02-13 Pharmacia Lkb Biotech Method and apparatus for analyzing polynucleotide sequences
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
DE69433180T2 (en) * 1993-10-26 2004-06-24 Affymetrix, Inc., Santa Clara FIELDS OF NUCLEIC ACID PROBE ON ORGANIC CHIPS
EP0889122A3 (en) 1993-11-30 1999-03-03 McGILL UNIVERSITY Inhibition of DNA Methyltransferase
US5858661A (en) * 1995-05-16 1999-01-12 Ramot-University Authority For Applied Research And Industrial Development Ataxia-telangiectasia gene and its genomic organization
US5871917A (en) 1996-05-31 1999-02-16 North Shore University Hospital Research Corp. Identification of differentially methylated and mutated nucleic acids
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
DE19750172C1 (en) * 1997-11-12 1998-10-01 Deutsches Krebsforsch DNA with promoter activity
JP2001526381A (en) * 1997-12-05 2001-12-18 マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ Nucleic acid identification method by matrix-assisted laser desorption / ionization mass spectrometry
WO2000005419A1 (en) * 1998-07-24 2000-02-03 Yeda Research And Development Company Ltd. Prevention of metastasis with 5-aza-2'-deoxycytidine
DE19905082C1 (en) * 1999-01-29 2000-05-18 Epigenomics Gmbh Identification of methylation patterns of cytosine in genome DNA comprises chemical treatment to produce different base pairing behavior between cytosine and 5-methylcytosine
US6331393B1 (en) * 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6783933B1 (en) * 1999-09-15 2004-08-31 The Johns Hopkins University School Of Medicine CACNA1G polynucleotide, polypeptide and methods of use therefor
US7668658B2 (en) * 1999-10-13 2010-02-23 Sequenom, Inc. Methods for generating databases and databases for identifying polymorphic genetic markers
WO2001077164A2 (en) 2000-04-06 2001-10-18 Epigenomics Ag Diagnosis of diseases associated with apoptosis by means of assessing the methylation status of genes associated with apoptosis
AU2001277521A1 (en) 2000-06-30 2002-01-14 Epigenomics Ag Diagnosis of diseases associated with cell signalling
DE10037769A1 (en) 2000-08-03 2002-02-21 Epigenomics Gmbh Diagnosis of diseases associated with CD24
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
DE10054972A1 (en) 2000-11-06 2002-06-06 Epigenomics Ag Diagnosis of diseases associated with humus
DE10054974A1 (en) 2000-11-06 2002-06-06 Epigenomics Ag Diagnosis of diseases associated with Cdk4
DE10128508A1 (en) 2001-06-14 2003-02-06 Epigenomics Ag Methods and nucleic acids for the differentiation of prostate tumors
WO2003004696A2 (en) * 2001-07-02 2003-01-16 Epigenomics Ag A distributed system for epigenetic based prediction of complex phenotypes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744305A (en) * 1989-06-07 1998-04-28 Affymetrix, Inc. Arrays of materials attached to a substrate
WO1998056952A1 (en) * 1997-06-09 1998-12-17 University Of Southern California A cancer diagnostic method based upon dna methylation differences
WO1999028498A2 (en) * 1997-11-27 1999-06-10 Epigenomics Gmbh Method for producing complex dna methylation fingerprints
WO2001068911A2 (en) * 2000-03-15 2001-09-20 Epigenomics Ag Diagnosis of diseases associated with the cell cycle

Non-Patent Citations (17)

* Cited by examiner, † Cited by third party
Title
"CHARACTERIZATION OF A PUTATIVE PROMOTER REGION OF THE HUMAN POLY(ADP-RIBOSE) POLYMERASE GENE: STRUCTURAL SIMILARITY TO THAT OF THE DNA POLYMERASE BETA GENE", BIOCHEM. BIOPHYS. RES. COMM., vol. 167, 1990, US, pages 701 - 710 *
AUER B. ET AL.: "HUMAN NUCLEAR NAD ADP-RIBOSYLTRANSFERASE( POLYMERIZING): ORGANIZATION OF THE GENE", DNA, vol. 8, no. 8, 1 October 1989 (1989-10-01), US, pages 575 - 580, XP000569183 *
DATABASE EBI [online] 1 February 1990 (1990-02-01), AUER ET AL.: "Human nuclear NAD+ ADP-rybosyltransferase (polymerizing): organization of the gene", XP002219548, Database accession no. m29544 *
DATABASE EBI [online] 1 July 1994 (1994-07-01), OGURA T. ET AL., XP002219551, Database accession no. X16674 *
DATABASE EBI [online] 23 July 1991 (1991-07-23), HERZOG H. ET AL.: "Human pADPRT is involved in the regulation of its own gene", XP002219550, Database accession no. M60436 *
DATABASE EBI [online] 23 October 1995 (1995-10-23), MACDONALD M., XP002219552, Database accession no. Z66254 *
DATABASE EBI [online] 24 March 1999 (1999-03-24), "National Cancer Institute, Cancer Genome Anatomy project (CGAP)", XP002219546, Database accession no. AI538438 *
DATABASE EBI [online] 30 January 2000 (2000-01-30), RAMSAY H., XP002219549, Database accession no. AL137852 *
DATABASE EBI [online] 5 October 2001 (2001-10-05), OLEK A. ET AL.: "Diagnosis of diseases associated with cell cycle", XP002219671, Database accession no. AX251771 *
DATABASE EBI [online] HILLIER L. ET AL.: "Generation and analysis of 280000 human expressed sequence tags", XP002219547, Database accession no. AA086258 *
DATABASE EBI 5 October 2001 (2001-10-05), OLEK A.: "Diagnosis of diseases associated with cell cycle", XP002219672 *
ESTELLER MANEL ET AL: "Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia.", CANCER RESEARCH, vol. 59, no. 4, 15 February 1999 (1999-02-15), pages 793 - 797, XP002182504, ISSN: 0008-5472 *
HAUG T. ET AL.: "Human uracyl-DNA glycosylase gene: sequence organization,methylation pttern, and mapping to chromosome 12q23-q24.1", GENOMICS, vol. 36, 1996, US, pages 408 - 416, XP002219668 *
HERMAN JAMES G ET AL: "Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 95, no. 12, 9 June 1998 (1998-06-09), June 9, 1998, pages 6870 - 6875, XP002219669, ISSN: 0027-8424 *
MACDONALD M. ET AL.: "Purification of CPG islands using a methylated DNA binding column", NATURE GENETICS, vol. 6, 1994, pages 236 - 244 *
REIN ET AL: "Identifying 5-methylcytosine and related modifications in DNA genomes", NUCLEIC ACIDS RESEARCH, OXFORD UNIVERSITY PRESS, SURREY, GB, vol. 26, no. 10, 1998, pages 2255 - 2264, XP002143106, ISSN: 0305-1048 *
WHEELER J M D ET AL: "Mechanisms of inactivation of mismatch repair genes in human colorectal cancer cell lines: The predominant role of hMLH1.", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, vol. 96, no. 18, 31 August 1999 (1999-08-31), Aug. 31, 1999, pages 10296 - 10301, XP002219670, ISSN: 0027-8424 *

Also Published As

Publication number Publication date
WO2001077376A8 (en) 2002-03-21
US20040067491A1 (en) 2004-04-08
EP1274865B1 (en) 2007-02-14
US20030162194A1 (en) 2003-08-28
WO2001081622A2 (en) 2001-11-01
AU2001276330B2 (en) 2006-08-31
WO2001092565A3 (en) 2002-09-06
US20050282157A1 (en) 2005-12-22
EP1274866A2 (en) 2003-01-15
WO2001077375A8 (en) 2002-10-24
EP1360319A2 (en) 2003-11-12
AU2001254794A1 (en) 2001-10-23
WO2001077377A3 (en) 2002-07-11
US20030148326A1 (en) 2003-08-07
US20040076956A1 (en) 2004-04-22
DE60126593D1 (en) 2007-03-29
AU2001289600A1 (en) 2001-12-11
AU2001277487A1 (en) 2001-10-23
WO2001092565A2 (en) 2001-12-06
WO2001077375A2 (en) 2001-10-18
EP2014776A3 (en) 2009-04-01
EP1268861A2 (en) 2003-01-02
JP2003531589A (en) 2003-10-28
WO2001076451A2 (en) 2001-10-18
AU2001254788A1 (en) 2001-10-23
AU7633001A (en) 2001-10-23
US20030148327A1 (en) 2003-08-07
WO2001076451A9 (en) 2002-08-08
US7195870B2 (en) 2007-03-27
EP1272670A2 (en) 2003-01-08
WO2001092565A8 (en) 2002-05-30
WO2001077164A8 (en) 2002-03-21
WO2001077377A2 (en) 2001-10-18
WO2001077164A2 (en) 2001-10-18
ATE353975T1 (en) 2007-03-15
EP2014776A2 (en) 2009-01-14
WO2001077375A3 (en) 2002-06-27
EP1274865A2 (en) 2003-01-15
EP1370685A2 (en) 2003-12-17
US20030082609A1 (en) 2003-05-01
WO2001076451A3 (en) 2003-09-04
JP2003534780A (en) 2003-11-25
WO2001077378A2 (en) 2001-10-18
WO2001081622A8 (en) 2002-05-16
WO2001077376A3 (en) 2002-08-08
WO2001077378A3 (en) 2002-10-17
EP1268857A2 (en) 2003-01-02
AU2001275663A1 (en) 2001-10-23
WO2001077164A3 (en) 2002-06-20
AU2001278420A1 (en) 2001-11-07
WO2001077377A8 (en) 2002-02-28
JP2004508807A (en) 2004-03-25
DE60126593T2 (en) 2007-10-31
AU2001276331A1 (en) 2001-10-23
WO2001077376A2 (en) 2001-10-18
EP1278893A2 (en) 2003-01-29

Similar Documents

Publication Publication Date Title
WO2001081622A8 (en) Diagnosis of diseases associated with dna repair
WO2001068911A3 (en) Diagnosis of diseases associated with the cell cycle
WO2002002807A8 (en) Diagnosis of diseases associated with cell signalling
WO2002077272A3 (en) Methods and nucleic acids for the analysis of hematopoietic cell proliferative disorders
WO2004035803A3 (en) Method and nucleic acids for the treatment of breast cell proliferative disorders
WO2003052135A8 (en) Method and nucleic acids for the analysis of a lung cell proliferative disorder
WO2003014388A3 (en) Method and nucleic acids for the analysis of colon cancer
WO2002046454A3 (en) Diagnosis of diseases associated with angiogenesis by determining the methylation of genes associated with angiogenesis
WO2002103042A3 (en) Method and nucleic acids for the differentiation of prostate tumors
WO2004020662A3 (en) Method and nucleic acids for the analysis of breast cell proliferative disorders
WO2002036814A3 (en) Diagnosis of diseases associated with cdk4 by determining the methylation state of the cdk4
WO2009044085A3 (en) Oligonucleotides, use, method of detection and kit for diagnosing the presence of the e1 gene of the chikungunya virus
WO2002012554A3 (en) Diagnosis of diseases which are associated with cd24
WO2002036604A3 (en) Diagnosis of diseases associated with the human c-mos gene
WO2002103041A3 (en) Method and nucleic acids for the differentiation of prostate and renal carcinomas

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: C1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: C1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

CFP Corrected version of a pamphlet front page
CR1 Correction of entry in section i

Free format text: PAT. BUL. 44/2001 UNDER "PUBLISHED", DELETE "SEQUENCE LISTING PART OF DESCRIPTION PUBLISHED SEPARATELY IN ELECTRONIC FORM AND AVAILABLE UPON REQUEST FROM THE INTERNATIONAL BUREAU."

CFP Corrected version of a pamphlet front page
WWE Wipo information: entry into national phase

Ref document number: 2001956429

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10240589

Country of ref document: US

WWP Wipo information: published in national office

Ref document number: 2001956429

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: JP